Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Head and Neck Neoplasms 5Mouth Neoplasms 4Leukoplakia, Oral 3Erythroplasia 3Thyroid Nodule 2Thyroid Neoplasms 2Thyroid Diseases 2Insulin Resistance 2Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Melanoma 1Lymphoid Interstitial Pneumonia 1Leukoplakia 1Laryngeal Diseases 1Hyperplasia 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Squamous Cell Cancer 1Endometrial Neoplasms 1Diabetes Mellitus, Type 2 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Breast Diseases 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 1Photochemotherapy 1Metformin 1Lasers, Solid-State 1Imiquimod 1Biopsy 1Aminolevulinic Acid 15-aminolaevulinic acid-n-pentylester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukoplakia × Metformin × Head & Neck × Clear all
NCT05536037 2025-05-15

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Thomas Jefferson University

Phase 1 Terminated
4 enrolled
Head & Neck

Erythroplasia, Leukoplakia, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡